05.05.2010 • News

Grime, Dust and Duct Tape Found at J&J Plant

U.S. inspectors who toured the Johnson & Johnson plant at the center of last week's recall of widely used liquid children's products uncovered unsanitary conditions in at least one lab, according to a government report released on Tuesday.

The U.S. Food and Drug Administration (FDA) said in the report, dated April 30, that its inspectors found thick dust and grime covering certain equipment, a hole in the ceiling and duct tape-covered pipes at the Fort Washington, Penn., facility where 40 products recalled last Friday were made. Inspectors also found a lack of quality control procedures and poor handling of complaints, according to the report.

On Saturday, the FDA urged consumers to stop using liquid Tylenol, Motrin, Benadryl and Zyrtec for children and infants after a broad recall by Johnson & Johnson's consumer division late on Friday. Read the full list of more than 40 affected products made by McNeil Consumer Healthcare here.

McNeil said it was recalling the products in consultation with the FDA after discovering manufacturing deficiencies that could affect the quality, purity or potency of the medicines. On Tuesday, the FDA posted the inspection notice.

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read